Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MBX Biosciences (MBX) Other financing activities (2024 - 2026)

MBX Biosciences has reported Other financing activities over the past 3 years, most recently at $378000.0 for Q1 2026.

  • Quarterly results put Other financing activities at $378000.0 for Q1 2026, changed N/A from a year ago — trailing twelve months through Mar 2026 was $1.1 million (down 71.67% YoY), and the annual figure for FY2025 was $771000.0, down 81.02%.
  • Other financing activities reached $378000.0 in Q1 2026 per MBX's latest filing, down from $517000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.9 million in Q3 2024 and bottomed at $6000.0 in Q1 2024.
  • Median Other financing activities over the past 3 years was $378000.0 (2026), compared with a mean of $744428.6.
  • Peak annual rise in Other financing activities hit 58.1% in 2025, while the deepest fall reached 86.76% in 2025.
  • Over 3 years, Other financing activities stood at $327000.0 in 2024, then soared by 58.1% to $517000.0 in 2025, then decreased by 26.89% to $378000.0 in 2026.
  • Business Quant data shows Other financing activities for MBX at $378000.0 in Q1 2026, $517000.0 in Q4 2025, and $254000.0 in Q3 2025.